Drug intelligence / Profile preview

JUVIA + fluconazole

Development stage
Unknown
Lead developer
Mycovia Pharmaceuticals
Modality
Small Molecules
Administration
Oral, Vaginal
01

Overview

JUVIA + fluconazole is a combination therapy being investigated for the treatment of recurrent vulvovaginal candidiasis (RVVC). The regimen consists of a single oral dose of **fluconazole** (150 mg), a systemic triazole antifungal, followed by a 12-week course of **JUVIA**, a topical zinc-containing vaginal gel. Fluconazole acts by inhibiting the fungal enzyme lanosterol 14-alpha-demethylase, which is essential for ergosterol synthesis and fungal cell membrane integrity. JUVIA provides a local, zinc-mediated antimicrobial effect that is intended to complement systemic treatment and prevent the recurrence of infection. The combination is currently being evaluated in a Phase 2 clinical trial (NCT05895162) sponsored by Juvia Bio.

Brand names
Diflucan
Other names
zinc + fluconazole
02

Targets

CYP51A1 (Sterol 14α-demethylase)

Beyond the preview

Go deeper on JUVIA + fluconazole.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on JUVIA + fluconazole.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call